Company Description
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications.
This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories.
Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software.
The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers.
Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
| Country | United States |
| Founded | 1952 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 7,450 |
| CEO | Norman Schwartz |
Contact Details
Address: 1000 Alfred Nobel Drive Hercules, California 94547 United States | |
| Phone | 510 724 7000 |
| Website | bio-rad.com |
Stock Details
| Ticker Symbol | BIO |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000012208 |
| CUSIP Number | 090572207 |
| ISIN Number | US0905722072 |
| Employer ID | 94-1381833 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Norman D. Schwartz | Chairman and Chief Executive Officer |
| Jonathan P. DiVincenzo | President and Chief Operating Officer |
| Roop K. Lakkaraju CPA | Executive Vice President and Chief Financial Officer |
| Michael Crowley | Executive Vice President of Global Commercial Operations |
| Anette Engelhardt | Executive Vice President and President of the Clinical Diagnostics Group |
| Yong Chung | Vice President of Investor Relations |
| Matthew Werner | Senior Vice President and Chief Compliance and Privacy Officer |
| Courtney C. Enloe | Executive Vice President, General Counsel and Secretary |
| Lee Boyd | Senior Vice President of Global Commercial Operations - Asia Pacific |
| James J. Barry | Executive Vice President and President of Life Science Group |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 19, 2026 | 8-K | Current Report |
| Feb 13, 2026 | 10-K | Annual Report |
| Feb 12, 2026 | 8-K | Current Report |
| Dec 2, 2025 | 144 | Filing |
| Nov 18, 2025 | 144 | Filing |
| Nov 6, 2025 | 144 | Filing |
| Oct 30, 2025 | SCHEDULE 13D/A | Filing |
| Oct 30, 2025 | SCHEDULE 13D/A | Filing |
| Oct 29, 2025 | 10-Q | Quarterly Report |
| Oct 29, 2025 | 8-K | Current Report |